Medical Journals

Nitric Oxide Donor Molsidomine Attenuates Psychotomimetic Effects of the Nmda Receptor Antagonist Mk-801.

Authors:
  • Pitsikas Nikolaos
  • Zisopoulou Styliani
  • Sakellaridis Nikolaos

From: Department of Pharmacology, School of Medicine, University of Thessaly, Larissa, Greece. npitsikas@med.uth.gr

Journal of neuroscience research

  • Publish Date: Aug 2006
  • ISSN: 0360-4012
  • Volume: 84
  • Issue: 2
  • Pages: 299-305
  • Medium: Print
  • Language: English
  • Citation (JAMA): Pitsikas Nikolaos, Zisopoulou Styliani, Sakellaridis Nikolaos, et al. Nitric Oxide Donor Molsidomine Attenuates Psychotomimetic Effects of the Nmda Receptor Antagonist Mk-801.. J. Neurosci. Res. Aug 2006;84:299-305

Abstract

There is experimental evidence indicating that the non-competitive NMDA receptor antagonist MK-801 impairs cognition and produces a series of schizophrenia-like symptoms in rodents (hypermotility, stereotypies, and ataxia). The present study was designed to investigate the efficacy of the nitric oxide (NO) donor molsidomine in counteracting these MK-801-induced behavioral effects in the rat. In a first study, post-training administration of molsidomine (at 4 but not 2 mg/kg) successfully antagonized MK-801-induced performance deficits in a recognition memory test. In a subsequent study, molsidomine (2 and 4 mg/kg) was shown to be unable to reverse MK-801-induced hypermotility but attenuated stereotypies (continuous movement whole cage, body sway, and head weaving) produced by MK-801. Moreover, at 4 mg/kg this NO donor counteracted MK-801-induced ataxia. Our findings indicate that molsidomine attenuates behavioral effects related to the hypofunction of the NMDA receptor suggesting that NO might be involved in the psychotomimetic effects of non-competitive NMDA receptor antagonists.

Mesh Headings (Keywords): Animals, Behavior, Animal, Brain, Dizocilpine Maleate, Excitatory Amino Acid Antagonists, Hallucinogens, Male, Memory, Molsidomine, Motor Activity, Nitric Oxide Donors, Rats, Receptors, N-Methyl-D-Aspartate


Check for Full Text / PubMed Unique Identifier (PMID): 16710846


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.